Michael J Cavnar Selected Research

Neoplasms (Cancer)

11/2023	ASO Visual Abstract: Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using the Codman Vascular Catheter with the Medtronic Synchromed II Pump for Intrahepatic Cancers.
11/2023	Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using The Codman Vascular Catheter with The Medtronic SynchroMed II Pump for Intrahepatic Cancers.
6/2022	Endogenous Pancreatic Cancer Cell PD-1 Activates MET and Induces Epithelial-Mesenchymal Transition to Promote Cancer Progression.
3/2022	Targetable IDH1 mutation identified in a rare case of pancreatic serous cystadenocarcinoma but not a series of serous cystadenomas.
1/2022	Interaction of immune checkpoint PD-1 and chemokine receptor 4 (CXCR4) promotes a malignant phenotype in pancreatic cancer cells.
1/2021	Prognostic Factors After Neoadjuvant Imatinib for Newly Diagnosed Primary Gastrointestinal Stromal Tumor.
1/2021	Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- and Post-imatinib Eras.
1/2021	Development of a Single-Cell Technique to Increase Yield and Use of Gastrointestinal Cancer Organoids for Personalized Medicine Application.
3/2020	An Organotypic Microcosm for the Pancreatic Tumor Microenvironment.
1/2019	Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael J Cavnar Research Topics

Disease

17	Neoplasms (Cancer) 11/2023 - 08/2011
7	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021 - 08/2011
4	Neoplasm Metastasis (Metastasis) 11/2023 - 12/2017
4	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2014
1	Infections 11/2023
1	COVID-19 11/2023
1	Adrenocortical Carcinoma 11/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 03/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021
1	Fibrosis (Cirrhosis) 05/2014
1	Ischemia 10/2012
1	Reperfusion Injury 10/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2012
1	Sepsis (Septicemia) 03/2011
1	Peritonitis 03/2011

Drug/Important Bio-Agent (IBA)

7	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 08/2011
2	Transcription Factors (Transcription Factor)IBA 12/2017 - 12/2013
2	CateninsIBA 12/2017 - 01/2017
2	Oncogene Proteins (Oncogene Protein)IBA 12/2013 - 08/2011
1	Floxuridine (FUdR)FDA LinkGeneric 11/2023
1	Proteins (Proteins, Gene)FDA Link 06/2022
1	ivosidenibIBA 03/2022
1	Chemokine ReceptorsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2017
1	TankyrasesIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Insulin-Like PeptidesIBA 01/2017
1	G007-LKIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	pexidartinibIBA 05/2014
1	CCAAT-Enhancer-Binding ProteinsIBA 12/2013
1	JNK Mitogen-Activated Protein KinasesIBA 10/2012
1	CytokinesIBA 10/2012
1	nilotinib FDA Link 10/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2012
1	Mitogen-Activated Protein KinasesIBA 10/2012
1	EnzymesIBA 08/2011
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 08/2011
1	Interleukin-10 (Interleukin 10)IBA 03/2011

Therapy/Procedure

7	Therapeutics 03/2021 - 08/2011
2	Drug Therapy (Chemotherapy) 11/2023 - 11/2023
2	Vascular Access Devices (Arterial Line) 11/2023 - 11/2023
1	Catheters 11/2023
1	Radiotherapy 03/2021
1	Precision Medicine 01/2021
1	Molecular Targeted Therapy 05/2014
1	Immunotherapy 08/2011